Summary Information:
Sage Therapeutics Inc. Common Stock
NASDAQ:SAGE


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Sage Therapeutics Inc. Common Stock
Exchange: NASDAQ
Symbol: SAGE
SEC CIK: 0001597553
Phone: 617-299-8380
215 FIRST STREET
CAMBRIDGE MA 02142

CEO: Jeffrey Jonas
Price when page updated: 19.62 Date: 2023-12-01
Company Website:
www.sagerx.com

_Description: Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. The Company is pursuing new pathways with the goal of improving brain health, and its depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Its mission is to make medicines that matter so people can get better, sooner.

IPO YEAR:
2014
Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
1176562664.00
Beta:
1.306218045165386
52 Week High:
98.39
52 Week Low:
36.13
52 Week Change:
-0.5111414279217825
Short Interest:

Short Date:

Shares Outstanding:
58908485
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
1 Nov 2022
Float:
0
return on Equity:
-30.10%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$518.01
ttmEPS:
11.07
Revenue:
$6.165M
Gross Profit:

Cash:

Debt:

Institution Percent:
88.30%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.20%
Return on Assets:
-28.50%
Return on Capital:

Profit Margin:
-
Price to Sales:
358.26
Price To Book:
1.43
Short Ratio:
8.00
PE Ratio:
3.9473362084414414
Employees:
298
1Y Guesstimate
54.582:1.0:6




__The following are links to various summary and news pages for
__Sage Therapeutics Inc. Common Stock [ SAGE ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01